A 12½-year journey of a patient with Samter triad syndrome and sporadic omalizumab use

Ann Allergy Asthma Immunol. 2015 Nov;115(5):454-6. doi: 10.1016/j.anai.2015.08.013. Epub 2015 Sep 29.

Authors

Ledit R F Ardusso¹, Hugo Neffen²

Affiliations

¹ Pulmonology, Allergy and Immunology Department, Rosario School of Medicine, National University of Rosario, Santa Fe, Argentina. Electronic address: ardussol@ciudad.com.ar.
² Respiratory Medicine Unit, Children Hospital Orlando Alassia, Santa Fe, Argentina.

PMID: 26392046
DOI: 10.1016/j.anai.2015.08.013

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged, 80 and over
Anti-Asthmatic Agents / therapeutic use*
Asthma, Aspirin-Induced / drug therapy*
Female
Humans
Omalizumab / therapeutic use*

Substances

Anti-Asthmatic Agents
Omalizumab